Brand name in Australia, Europe and Latin America for imatinib mesylate, the first generation tyrosine kinase inhibitor used in the treatment of Ph+CML as well as some other cancers; known as Gleevec in Canada, South Africa and the USA.
Brand name in Australia, Europe and Latin America for imatinib mesylate, the first generation tyrosine kinase inhibitor used in the treatment of Ph+CML as well as some other cancers; known as Gleevec in Canada, South Africa and the USA.
There is currently no content classified with this term.